Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates.
Paul ED, Huraiová B, Valková N, Birknerova N, Gábrišová D, Gubova S, Ignačáková H, Ondris T, Bendíková S, Bíla J, Buranovská K, Drobná D, Krchnakova Z, Kryvokhyzha M, Lovíšek D, Mamoilyk V, Mančíková V, Vojtaššáková N, Ristová M, Comino-Méndez I, Andrašina I, Morozov P, Tuschl T, Pareja F, Čekan P. Paul ED, et al. Among authors: andrasina i. medRxiv [Preprint]. 2023 Dec 6:2023.12.05.23299341. doi: 10.1101/2023.12.05.23299341. medRxiv. 2023. PMID: 38105959 Free PMC article. Preprint.
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC.
Planchard D, Jänne PA, Cheng Y, Yang JC, Yanagitani N, Kim SW, Sugawara S, Yu Y, Fan Y, Geater SL, Laktionov K, Lee CK, Valdiviezo N, Ahmed S, Maurel JM, Andrasina I, Goldman J, Ghiorghiu D, Rukazenkov Y, Todd A, Kobayashi K; FLAURA2 Investigators. Planchard D, et al. Among authors: andrasina i. N Engl J Med. 2023 Nov 23;389(21):1935-1948. doi: 10.1056/NEJMoa2306434. Epub 2023 Nov 8. N Engl J Med. 2023. PMID: 37937763 Clinical Trial.
Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population.
Šafčák D, Dražilová S, Gazda J, Andrašina I, Adamcová-Selčanová S, Barila R, Mego M, Rác M, Skladaný Ľ, Žigrai M, Janičko M, Jarčuška P. Šafčák D, et al. Among authors: andrasina i. Curr Oncol. 2023 Mar 22;30(3):3557-3570. doi: 10.3390/curroncol30030271. Curr Oncol. 2023. PMID: 36975484 Free PMC article.
Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers.
Safcak D, Drazilova S, Gazda J, Andrasina I, Adamcova-Selcanova S, Balazova L, Barila R, Mego M, Rac M, Skladany L, Zigrai M, Janicko M, Jarcuska P. Safcak D, et al. Among authors: andrasina i. J Clin Med. 2022 Jul 19;11(14):4183. doi: 10.3390/jcm11144183. J Clin Med. 2022. PMID: 35887947 Free PMC article.
Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival-A Retrospective Analysis of a Slovak Cohort.
Safcak D, Drazilova S, Gazda J, Andrasina I, Adamcova-Selcanova S, Barila R, Mego M, Rac M, Skladany L, Zigrai M, Janicko M, Jarcuska P. Safcak D, et al. Among authors: andrasina i. J Clin Med. 2021 Jul 20;10(14):3186. doi: 10.3390/jcm10143186. J Clin Med. 2021. PMID: 34300352 Free PMC article.
Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial.
Zemanova M, Cernovska M, Havel L, Bartek T, Lukesova S, Jakesova J, Vanasek J, Reiterer P, Kultan J, Andrasina I, Siskova L, Koubkova L, Skrickova J, Salajka F, Pesek M, Klepetko P, Beniak J, Fricke H, Kadlecova P, Korolkiewicz RP, Hraska M, Bartunkova J, Spisek R. Zemanova M, et al. Among authors: andrasina i. Cancer Treat Res Commun. 2021;28:100427. doi: 10.1016/j.ctarc.2021.100427. Epub 2021 Jun 26. Cancer Treat Res Commun. 2021. PMID: 34284344 Free article. Clinical Trial.
Occurrence of two histopathologically different malignancies.
Tokarčík J, Slížová D, Andrašina I, Šafčák D, Rudnay M, Demková K. Tokarčík J, et al. Among authors: andrasina i. Klin Onkol. 2021 Spring;34(2):147-150. doi: 10.48095/ccko2021147. Klin Onkol. 2021. PMID: 33906364 English.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Każarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L; CASPIAN investigators. Goldman JW, et al. Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4. Lancet Oncol. 2021. PMID: 33285097 Clinical Trial.
Differential Urinary Proteomic Analysis of Endometrial Cancer.
Kacírová M, Bober P, Alexovič M, Tomková Z, Tkáčiková S, Talian I, Mederová L, Bérešová D, Tóth R, Andrašina I, Kožlejová Z, Kilík R, Divín R, Sabo J. Kacírová M, et al. Among authors: andrasina i. Physiol Res. 2019 Dec 30;68(Suppl 4):S483-S490. doi: 10.33549/physiolres.934375. Physiol Res. 2019. PMID: 32118480 Free article.
12 results